Patients with metastatic PDAC, NSCLC, HR+/HER2- ductal and lobular BC, TNBC, CRC or STS. research hub

A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors

This early study checks how a new drug, JFI447, works in people with certain advanced cancers, including pancreatic, lung, breast, bowel, and soft tissue cancers. Researchers are also comparing it with another drug, FFG233, to see how both show up on scans.